Breaking news: 3 million mammograms and counting Read News

Smart AI for early breast cancer detection and diagnosis

We focus on improving breast cancer survival rates by detecting cancers earlier and making treatment more effective and less intense.

FDA cleared for use on all major 2D and 3D mammography systems. 

LEARN ABOUT OUR CLINICAL EVIDENCE HERE

An introduction to Screenpoint

Here’s a short introduction to what we do

Why Transpara?

Trusted in more than 30 countries

Trusted in more than 30 countries

FDA cleared and CE marked for 2D and 3D mammography

FDA cleared and CE marked for 2D and 3D mammography

The most independent peer reviewed publications in breast AI

The most independent peer reviewed publications in breast AI

Proven multivendor compatibility

Proven multivendor compatibility

Integrated with most workstations

Integrated with most workstations

Experience the benefit of our continuously evolving deep learning algorithm

Experience the benefit of our continuously evolving deep learning algorithm

Peer Reviewed Publications

Accuracy.
Workload Reduction.
Risk.

"Transpara has the potential to detect specific cancers earlier. I can think of 1-2 recent cases with calcifications, where Transpara detected a cancer earlier that was not easily visible on a mammogram."

Dr Brian Englander

Dr Englander, Robert E. Campbell Professor of Clinical Radiology, Perelman School of Medicine Chairman, Department of Radiology, Pennsylvania Hospital Penn Center for Global Health Scholar

"Transpara increases my confidence and efficiency going through a screening mammography session. I have more focus especially with the higher risk cases thanks to their Intuitive Triage software."

Dr Roger Yang

MD, FACR, University Radiology Group

"I use Transpara all the time, and won't read another 3D mammogram without it. The product fits seamlessly into our workflow, and we have found over time it has increased our mammography workflow. Thanks to the technology's score card we are also able to focus on those high risk patients first, and get those patients the care they may need faster."

Dr Daniel Gurell

Vice President and Associate Medical Director at University Diagnostic Medical Imaging P.C.USA

“Transpara may allow discriminating studies, which require more attention and selection of those, which may be handled with single reading for example. It may thus contribute significantly to both risk adapted screening and optimum assignment of resources."

Professor Sylvia H Heywang-Köbrunner

Radiologist, Head of the Referenzzentrum Mammographie Munich, Germany

"We are at the forefront of one of the first prospective studies with Transpara. As we will implement Transpara in a real-life screening setting in Ostergotland County, we aim to improve the quality of the breast cancer screening program while at the same time safely reduce the workload of breast radiologists."

Håkan Gustafsson

Deputy Director CMIV, AI Coordinator at Region Östergötland

The Transpara Process

The Transpara Process
Client scan

Client scan

Client undergoes mammogram

Analyze scan

Analyze scan

Transpara analyses mammogram scan

Reading with Transpara

Reading with Transpara

Radiologist reads with support from Transpara, increasing confidence in decision

Result

Make more accurate and consistent decision

News

Announcement


ScreenPoint Medical Announces its new International Medical Advisory Board

ScreenPoint Medical, the company that developed the world leading Transpara® AI breast care system, today announced the launch of its

Read more

Trade shows


EUSOBI 2022 – The Scandinavian Breast AI Experience

Scandinavia is at the forefront of research and adoption of AI in breast screening. Are you attending EUSOBI 2022 in

Read more

Announcement


ScreenPoint Medical’s Transpara® AI reads over three million mammograms

Transpara, the world’s leading artificial intelligence (AI) breast care software, has now reached a major new milestone, helping radiologists read

Read more

Media coverage


A New Vision for ScreenPoint Medical

CEO Mark Koeniguer sets out his vision for the leader in Breast Cancer AI to grow and develop.  Watch the

Read more

Announcement


Transpara breast AI; strong clinical evidence evolves into real life screening use

Safely reducing radiologists’ workload for 2D and 3D mammography screening The Transpara AI breast care solution, now being used in

Read more

Publication


Transpara® breast AI reduces false positives and radiologists’ workload in largest Danish screening programme

The team running the country’s largest breast screening programme have shown that using Transpara breast AI further confirmed the enormous

Read more